# Meerkat Holding

> Meerkat Holding is a VC fund in Westphalia backing Health Care and Therapeutics. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Westphalia, United States
- Total investments: 4
- Last investment: Aug 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/meerkat-holding/
- Website: https://www.meerkat.de

Meerkat Holding is a VC fund in Westphalia focused on Health Care and Therapeutics. Meerkat Holding focus on software solutions in healthcare and industrial sectors.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Therapeutics | 1 | 25% |
| Biotechnology | 1 | 25% |
| Medical Device | 1 | 25% |
| Personal Health | 1 | 25% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 50% |
| Pre-Seed | 1 | 25% |
| Convertible Note | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Breathment | Digitizing pulmonary rehabilitation to empower health professionals with AI, reduce their workload and enable them to provide better care for their patients. | $934.8K | Pre-Seed | Aug 29, 2025 |  |
| Detechgene | Detechgene is a biotechnology company that develops a cartridge system for diagnosis. | $3.7M | Seed | Aug 25, 2025 |  |
| Skinuvita | Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home. | $2M | Seed | Jul 15, 2024 |  |
| icho systems | ichó is the smart therapy system for people with neurological conditions such as dementia, stroke or Parkinson's disease.The therapeutic care of these patients is already a major challenge today. Due to demographic change and a shortage of skilled labour, there is a risk of undersupply. The innovative medical device, the ichó therapy ball,provides patients with a smart device that stimulates and guides them in the implementation of therapeutic measures. The ichó applications give patients access to guideline-compliant therapy programmes, while the smart patient monitoring transparently displays the therapy process with real-world data.While smartphone apps or tablet solutions are already a challenge for patients to use, ichó has been specially developed for people with cognitive and motor impairments. The smart therapy ball recognises all interactions such as rolling, catching or shaking and reacts with coloured light, sound or music depending on the programme. Together with therapists, there are over 150 guideline-compliant therapy applications that stimulate patients' cognitive and motor skills. The effectiveness of ichó is confirmed by medical professionals and evaluations.Since its market launch in 2020, ichó has already been used in over 850 facilities. In mid-2023, based on the evaluations, the ichó therapy programme was funded by the care insurance funds for the first time as a preventive service in accordance with Section 5 SGB XI.The goal of ichó is to provide outpatient care for all patients at home. | $200K | Convertible Note | Feb 01, 2024 |  |

4 of 4 investments shown.

## Co-investors
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund, 2 deals together
- [Aquarius Invest](https://shizune.co/investors/profile/aquarius-invest) — VC Fund, 1 deal together
- [Bremer Aufbau-Bank GmbH](https://shizune.co/investors/profile/bremer-aufbau-bank-gmbh) — VC Fund, 1 deal together
- [Campus Capital](https://shizune.co/investors/profile/campus-capital-4272) — VC Fund, 1 deal together
- [Die Brückenköpfe](https://shizune.co/investors/profile/die-br%C3%BCckenk%C3%B6pfe) — VC Fund, 1 deal together
- [GIMIC Ventures](https://shizune.co/investors/profile/gimic-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Meerkat Holding invest in?

Meerkat Holding invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Meerkat Holding last invest?

The most recent investment recorded for Meerkat Holding closed in Aug 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co